The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we can even measure the size of them that also appears to be almost as crude as what the cholesterol concentration is but to come up with an assay that truly measures functionality may be beyond the scope of laboratories whereas with the apobldl side of the equation it really appears to be a stochastic problem the more of these things you have to the first order the more problems you have
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
if you are doing ion mobility or nmrs you can get an hdl particle count but that although it might be a tad better than hdl cholesterol telling you something there's so many exceptions to that rule that it's not a useful bedside metric either